These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 22016502)

  • 81.
    van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
    Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
    [No Abstract]   [Full Text] [Related]  

  • 82. Prognostic factors for death from visceral leishmaniasis in patients treated with liposomal amphotericin B in an endemic state in Brazil.
    Dias Tourinho B; Figueiredo Amâncio F; Lencine Ferraz M; Carneiro M
    Trans R Soc Trop Med Hyg; 2017 Apr; 111(4):163-171. PubMed ID: 28673017
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™).
    Goswami RP; Goswami RP; Das S; Satpati A; Rahman M
    Am J Trop Med Hyg; 2016 Jan; 94(1):93-8. PubMed ID: 26526926
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia.
    Diro E; Lynen L; Gebregziabiher B; Assefa A; Lakew W; Belew Z; Hailu A; Boelaert M; van Griensven J
    Trop Med Int Health; 2015 Jan; 20(1):8-16. PubMed ID: 25329449
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Relapsing visceral leishmaniasis in a HIV-1 infected patient with advanced disease.
    Standaert D; Laurent F; Jonckheere S; Scheiff JM; Vandercam B; Yombi JC
    Acta Clin Belg; 2013; 68(2):124-7. PubMed ID: 23967722
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India.
    Fakiola M; Singh OP; Syn G; Singh T; Singh B; Chakravarty J; Sundar S; Blackwell JM
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007673. PubMed ID: 31419223
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project.
    Ostyn B; Malaviya P; Hasker E; Uranw S; Singh RP; Rijal S; Sundar S; Dujardin JC; Boelaert M
    Trop Med Int Health; 2013 Jun; 18(6):725-33. PubMed ID: 23464638
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
    Berhe N; Abraham Y; Hailu A; Ali A; Mengistu G; Tsige K; Abebe Y
    East Afr Med J; 2001 Nov; 78(11):608-10. PubMed ID: 12219968
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis.
    Mohamed-Ahmed AH; Brocchini S; Croft SL
    Curr Opin Infect Dis; 2012 Dec; 25(6):695-702. PubMed ID: 23147810
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases.
    Thakur CP; Singh RK; Hassan SM; Kumar R; Narain S; Kumar A
    Trans R Soc Trop Med Hyg; 1999; 93(3):319-23. PubMed ID: 10492770
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Successful therapeutic splenectomy in an HIV patient with relapsing visceral leishmaniasis.
    Alon D; Chowers M
    Int J STD AIDS; 2012 Apr; 23(4):289-90. PubMed ID: 22581957
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome).
    Russo R; Nigro LC; Minniti S; Montineri A; Gradoni L; Caldeira L; Davidson RN
    J Infect; 1996 Mar; 32(2):133-7. PubMed ID: 8708370
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.
    Borges MM; Pranchevicius MC; Noronha EF; Romero GA; Carranza-Tamayo CO
    Rev Soc Bras Med Trop; 2017; 50(1):67-74. PubMed ID: 28327804
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
    Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
    Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol.
    Khodabandeh M; Rostami A; Borhani K; Gamble HR; Mohammadi M
    Parasitol Int; 2019 Oct; 72():101934. PubMed ID: 31129197
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use.
    Sundar S; Singh A; Rai M; Prajapati VK; Singh AK; Ostyn B; Boelaert M; Dujardin JC; Chakravarty J
    Clin Infect Dis; 2012 Aug; 55(4):543-50. PubMed ID: 22573856
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study.
    Thakur CP; Pandey AK; Sinha GP; Roy S; Behbehani K; Olliaro P
    Trans R Soc Trop Med Hyg; 1996; 90(3):319-22. PubMed ID: 8758093
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Liposomal amphotericin B as a treatment for human leishmaniasis.
    Balasegaram M; Ritmeijer K; Lima MA; Burza S; Ortiz Genovese G; Milani B; Gaspani S; Potet J; Chappuis F
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):493-510. PubMed ID: 23167833
    [TBL] [Abstract][Full Text] [Related]  

  • 100. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).
    Rabi Das VN; Siddiqui NA; Pal B; Lal CS; Verma N; Kumar A; Verma RB; Kumar D; Das P; Pandey K
    PLoS One; 2017; 12(3):e0174497. PubMed ID: 28355259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.